Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 856,851 ordinary shares
- Purchase Date: April 30, 2025
- Highest Price Paid: 377.30 pence per share
- Lowest Price Paid: 370.00 pence per share
- Volume Weighted Average Price: 373.28 pence per share
- Post-Transaction Share Capital: 9,020,990,697 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,016,910,492
Material Changes
The primary material change is the reduction of the Company's share capital through the cancellation of 856,851 shares. Consequently, the number of ordinary shares with voting rights has been updated to 9,016,910,492, a figure shareholders must use for determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation of an offer for securities. A full breakdown of individual trades is referenced as available via the London Stock Exchange and the Company's website.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the March 28, 2025 Buyback Programme.
- Confirm the updated number of voting shares (9,016,910,492) for compliance with disclosure thresholds.
- Review the full trade breakdown at the provided RNS link for detailed execution data.
- Note that this filing does not contain operational or financial performance data for the period.